M&G PLC Hutchmed (China) LTD Transaction History
M&G PLC
- $16.6 Billion
- Q2 2025
A detailed history of M&G PLC transactions in Hutchmed (China) LTD stock. As of the latest transaction made, M&G PLC holds 259,617 shares of HCM stock, worth $4.23 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
259,617
Previous 258,693
0.36%
Holding current value
$4.23 Million
Previous $3.89 Million
0.44%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding HCM
# of Institutions
60Shares Held
6.29MCall Options Held
9.9KPut Options Held
9.6K-
Schroder Investment Management Group London, X02.84MShares$46.4 Million0.05% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M925KShares$15.1 Million0.02% of portfolio
-
State Street Corp Boston, MA337KShares$5.49 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$5.14 Million0.11% of portfolio
-
Jane Street Group, LLC New York, NY222KShares$3.62 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.82B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...